Latest News and Press Releases

Pre-quarterly Results Communication Sanofi (EURONEXT: SAN and NYSE: SNY) has compiled the following items for consideration to assist in the financial modeling of the Group's Q2 2016 results. As...

Mise en ligne du document «Pre-quarterly Results Communication » Paris, France - Le 8 juillet 2016 - Sanofi annonce la mise en ligne sur l'espace Investisseurs du site internet de la société, d'un...

Availability of the Pre-quarterly Results Communication Paris, France - July 8, 2016 - Sanofi announced today that its Pre-Quarterly Results Communication document is available on the "Investors"...

Sanofi Pasteur signe un accord de recherche portant sur un vaccin contre le virus Zika - Le Walter Reed Army Institute of Research va effectuer un transfert de technologie - Paris, France - Le 6...

Sanofi Pasteur Signs Research Agreement for Zika Vaccine - Walter Reed Army Institute of Research to transfer technology - Paris, France - July 6, 2016 - Sanofi and its vaccines global...

Sanofi signe un accord de confidentialité avec Medivation et aura accès à une due diligence et à de l'information confidentielle - Sanofi accepte la clause de « standstill » et consent à arrêter le...

Sanofi Enters into Confidentiality Agreement with Medivation and Will be Provided Due Diligence Access and Confidential Information - Sanofi Agrees to Standstill and to Withdraw Consent...

Sanofi et Regeneron annoncent l'approbation au Japon de Praluent® (alirocumab) dans le traitement de l'hypercholestérolémie Paris (France) et Tarrytown (New York) - Le 5 juillet 2016 - Sanofi et...

Sanofi and Regeneron Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in Japan Paris, France and Tarrytown, New York - July 5, 2016 - Sanofi and Regeneron...

Sanofi and Boehringer Ingelheim have reached definitive agreements to swap Sanofi's Animal Health and Boehringer Ingelheim's Consumer Healthcare businesses- Both companies expected to become global...